UK Signs Historic Trade Deal with Gulf States Poised to Boost Economy by Billions Microsoft in Talks to Supply Custom AI Chips to Anthropic After 5 Billion Investment Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Micron Shares Surge to Record High Following Analyst PriceTarget Upgrade Smallcase Managers Forecast Nifty 50 Could Reach 2800030000 by FY27 Amid 9 YTD Decline Inflation Pinch Intensifies for US Consumers Ahead of Memorial Day Weekend MMI Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Market Conditions ACMR Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Drives Profitability BCH Q4 2025 Earnings EPS Misses Estimates Amid Challenging Operating Environment CMBT Q1 2026 Earnings Massive EPS Beat of 432 Drives Investor Attention Despite Stock Dip MNSO Q4 2025 Earnings EPS Surges 88 Above Estimates Despite Revenue Silence Stock Slips FCPT Q1 2026 Earnings EPS Misses Estimates on Lower Income Stock Holds Steady SBC Medical Group Holdings SBC Edges Lower Amid Light Trading Key Levels in Focus Murano Global Investments Warrants MRNOW Hold Steady at 004 as Trading Remains RangeBound Xcel Energy Junior Subordinated Notes XELLL Hold Steady Near Key Support Organon OGN Holds Near Support at 1335 as Stock Consolidates Frontier Group Holdings ULCC Edges Higher as UltralowCost Carrier Navigates Competitive Pressures ICON Q4 2025 Earnings WiderthanExpected Loss Amid Challenging Operational Environment KTTA Q1 2026 Earnings NarrowerThanExpected Loss Surprises Markets as Stock Slips KYEC Expands Singapore Operations with New Chip Testing Facility Creating Over 300 Jobs Beyond Oil Ltd Enters Revenue Execution Phase as US Foodservice Adoption Accelerates Heartbeam Inc BEAT Q1 2026 Earnings EPS Beat Estimates Amid PreRevenue Stage Stock Edges Higher VTGN Q1 2026 Earnings NarrowerthanExpected Loss as Vistagen Advances Pipeline Stock Edges Lower Government Plans to Sell Up to 2 Stake in Coal India as Profit Declines in FY26 Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development CanFite Biopharma CANF Edges Lower as Stock Tests Support Near 321